STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Technology IT Services

Palantir Reports Record Q4 Results, Solidifies Role in AI Revolution

byLuca Blaumann
February 3, 2025
in IT Services, Large-Cap, Software
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

U.S. Revenue Surges 52% YoY as Commercial and Government Sectors Drive Growth

Palantir Technologies (PLTR) has announced its financial results for the fourth quarter and fiscal year ending December 31, 2024, marking a standout performance that underscores its growing dominance in the AI sector.

“Our business results continue to astound, demonstrating our deepening position at the center of the AI revolution,” said Alexander C. Karp, Co-Founder and CEO of Palantir. “Our early insights surrounding the commoditization of large language models have evolved from theory to fact.”

Q4 2024 Highlights

Palantir’s U.S. revenue grew 52% year-over-year (YoY) and 12% quarter-over-quarter (QoQ), reaching $558 million. U.S. commercial revenue surged 64% YoY and 20% QoQ to $214 million, while U.S. government revenue climbed 45% YoY and 7% QoQ to $343 million. Overall revenue increased 36% YoY and 14% QoQ to $828 million.

The company closed 129 deals valued at least $1 million, including 58 deals over $5 million and 32 deals exceeding $10 million. U.S. commercial total contract value (TCV) hit a record $803 million, up 134% YoY and 170% QoQ, with remaining deal value (RDV) soaring 99% YoY to $1.79 billion.

Customer count grew 43% YoY and 13% QoQ, reflecting Palantir’s expanding footprint. Cash from operations reached $460 million (56% margin), while adjusted free cash flow was $517 million (63% margin). The company reported GAAP net income of $79 million (10% margin), rising to $165 million (20% margin) when excluding one-time stock appreciation rights (SARs) expenses.

Full-Year 2024 Highlights

For the fiscal year 2024, U.S. revenue grew 38% YoY to $1.90 billion, driven by a 54% increase in U.S. commercial revenue to $702 million and a 30% rise in U.S. government revenue to $1.20 billion. Total revenue reached $2.87 billion, up 29% YoY.

Palantir’s cash from operations totaled $1.15 billion (40% margin), with adjusted free cash flow of $1.25 billion (44% margin). GAAP net income was $462 million (16% margin), and income from operations hit $310 million (11% margin). Excluding SAR-related expenses, income from operations rose to $442 million (15% margin). Adjusted income from operations was $1.13 billion (39% margin).

Outlook for 2025

Looking ahead, Palantir expects Q1 2025 revenue between $858 million and $862 million, with adjusted income from operations ranging from $354 million to $358 million. For the full year 2025, revenue is projected between $3.741 billion and $3.757 billion, with U.S. commercial revenue exceeding $1.079 billion—a growth rate of at least 54%.

Adjusted income from operations is forecasted between $1.551 billion and $1.567 billion, while adjusted free cash flow is expected to range from $1.5 billion to $1.7 billion. The company anticipates GAAP operating income and net income in each quarter of 2025, reflecting continued profitability.

Palantir’s robust financial results highlight its strategic positioning in the AI landscape, driven by both commercial and government demand. With strong revenue growth, expanding customer base, and solid cash flow, Palantir is poised for continued success in 2025 and beyond.

Read original press release here

You might like this article:HCW Biologics Gains FDA Clearance for First-in-Human Trial of Novel Alopecia Areata Treatment

Tags: BreakingGrowthMoversNewsPalantirPLTRStock Market
Previous Post

HCW Biologics Gains FDA Clearance for First-in-Human Trial of Novel Alopecia Areata Treatment

Next Post

Spotify Surges After Reporting First Full-Year Profit

Related Posts

Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

byLuca Blaumann
May 8, 2025
0

BTC Inc. CEO’s “Nakamoto” venture to go public via Nasdaq merger, aims to acquire and hold Bitcoin at scale David...

Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds

byLuca Blaumann
May 7, 2025
0

Q1 Bookings Slightly Miss Estimates, But Profitable Growth and Autonomous Vehicle Plans Highlight Long-Term Vision Uber (UBER) delivered mixed results...

investing

AMD Kicks Off 2025 With Strong Q1 Growth Driven by AI and Data Center Demand

byLiliana Vida
May 6, 2025
0

Revenue Soars 57% in Data Center Segment as AMD Expands AI Partnerships and Product Leadership Advanced Micro Devices (AMD) delivered...

Next Post
investing

Spotify Surges After Reporting First Full-Year Profit

Latest News

Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds

AMD Kicks Off 2025 With Strong Q1 Growth Driven by AI and Data Center Demand

Constellation Energy Shares Surge on Revenue Beat and AI-Driven Demand

Based on Your Interest

IT Services

Palantir Soars in Q1 2025 with 39% Revenue Growth, Raises Full-Year Outlook Amid Soaring U.S. Commercial Demand

May 5, 2025
drugs-3
Biotechnology

Hims & Hers Health Doubles Revenue in Q1 2025, Raises Full-Year Outlook

May 5, 2025
amazon
Internet

Amazon Delivers Strong Q1 Results but Cautions on Tariffs and Trade Pressures

May 1, 2025

Recommended

Entertainment

Meta Delivers Strong Q1 Results as AI Push Accelerates, but EU Regulation Looms

April 30, 2025
Artificial Intelligence

Qualcomm Tops Q2 Expectations but Cautions on Trade Risks and Smartphone Demand

April 30, 2025
Artificial Intelligence

Nvidia CEO Urges U.S. to Loosen AI Export Rules Amid Rising Global Competition

April 30, 2025
Biotechnology

Novo Nordisk Expands Wegovy Access Through Telehealth Providers

April 29, 2025
Aerospace & Defense

Boeing Shares Climb After Analyst Upgrade and Spirit AeroSystems Breakthrough

April 28, 2025
Stoxpo

Follow us on social media:

Highlights

  • Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform
  • Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm
  • Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds
  • AMD Kicks Off 2025 With Strong Q1 Growth Driven by AI and Data Center Demand
  • Constellation Energy Shares Surge on Revenue Beat and AI-Driven Demand

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

chemistry

Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

May 8, 2025

Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

May 8, 2025

Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds

May 7, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?